1Davidson A, Diamond B. Autoimmune diseases. N Engl J Med,2001, 345:340-350.
2Tyndall A, Gratwohl A. The use of high dose immunoablative therapy with hematopoietic stem cell support therapy in the treatment of severe autoimmune diseases. Int J Hematol, 2002,76 Suppl 1 :218-222.
3Van Laar JM, Tyndall A. Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review. Cancer Control, 2003, 10:57-65.
4Kozak T, Rychlik I. Developments in hematopoietic stem-cell transplantation in the treatment of autoimmune diseases. Isr Med Assoc J,2002, 4:268-271.
5Petri M, Jones RJ, Brodsky RA. High-dose cyclophosphamide without stem cell transplantation in systemic lupus ervthematosus. Arthritis Rheum, 2003,48:166-173.
6Traynor AE, Barr WG, Rosa RM, et al. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis Rheum, 2002, 46:2917-2923.
7van Bekkum DW. Stem cell transplantation in experimental models of autoimmune disease. J Clin lmmunol, 2000, 20:10-16.
8Burt RK, Fassas A, Snowden J, et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant, 2001,28:1-12.
10Snowden JA, Biggs JC, Milliken ST, et al. A randomised, blinded,placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant,1998, 22:1035-1041.
